Work

Extended validation of the RR6 prognostic model at 6 and 12 months in primary and secondary myelofibrosis patients treated with ruxolitinib

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-7350

Authors: Erika Morsia, Dorela Lame, Michelangelo Pianelli, Giorgio Gramazio, Sonia More', Shahram Kordasti, Serena Rupoli, Antonella Poloni

Institution: Marche Polytechnic University

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417010081

Cites:

Cited by:

Related to: